36E79722A0026↗
Alexion Pharmaceuticals Inc received this contract vehicle from Nac Pharmaceuticals (36E797), Department of Veterans Affairs: $0 obligated so far for drugs and biologicals. Its period of performance ended 2026-07-24.
Key facts · data as of Oct 25, 2026
- Recipient
- Alexion Pharmaceuticals Inc
- Awarding agency
- Department of Veterans Affairs
- Contracting office
- Nac Pharmaceuticals (36E797) (36E797)
- Obligated to date
- $0
- Potential value
- $4.24M
- Ends
- 2026-07-24
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 36E79722A0026, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_IDV_36E79722A0026_3600
Alexion Pharmaceuticals Inc: all federal awards · Department of Veterans Affairs: spending · Nac Pharmaceuticals (36E797): what it buys
BPA FOR STRENSIQ
What it is
- Product or service
- Drugs and Biologicals (PSC 6505)
- Industry
- Pharmaceutical Preparation Manufacturing (NAICS 325412)
- Contracting office
- Nac Pharmaceuticals (36E797) (36E797)
- Competition
- Full and open competition · 1 offer received
- Pricing
- Firm fixed price
- How it was bought
- Contract vehicle (IDV) itself · under 36F79718D0355
- Solicitation
- VA-797P-12-Q-0002
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Orders under this vehicle
1 order worth $104.7K (current value). The largest:
- 36C24526N0739 · $104.7K · ends 2026-07-23
Every action
8 actions since 2022-12-05. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-07-24 | P00008 | Legal contract cancellation | $0 | THIS MODIFICATION IS ISSUED TO CANCEL BPA 36E79722A0026 IN ITS ENTIRETY AS THE PARENT FSS CONTRACT 36F79718D0355 HAS EXPIRED. A NEW BPA WILL BE ISSUED UNDER THE NEW FSS CONTRACT 36F79726D0143. |
| 2025-12-08 | P00007 | Supplemental agreement (work within scope) | $0 | 2026 PUBLIC LAW PRICING UPDATES. |
| 2025-07-14 | P00006 | Option exercised | $0 | THIS MODIFICATION IS ISSUED TO EXERCISE OPTION YEAR 3 ON BPA 36E79722A0026. |
| 2024-12-17 | P00005 | Supplemental agreement (work within scope) | $0 | 2025 PUBLIC LAW PRICING UPDATES |
| 2024-08-05 | P00004 | Option exercised | $0 | EXERCISE OPTION YEAR 2 FOR BPA 36E79722A0026. |
| 2023-12-13 | P00003 | Supplemental agreement (work within scope) | $0 | 2024 PUBLIC LAW PRICING UPDATES |
| 2023-07-18 | P00002 | Option exercised | $0 | EXERCISE OPTION YEAR 1 ON BPA 36E79722A0026. THE PERIOD OF PERFORMANCE IS 09/1/2023 - 08/31/2024. |
| 2022-12-05 | P00001 | Supplemental agreement (work within scope) | $0 | 2023 PUBLIC LAW PRICING UPDATES |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗